SIFTAXYS Trademark

Trademark Overview


On Friday, March 21, 2025, a trademark application was filed for SIFTAXYS with the United States Patent and Trademark Office. The USPTO has given the SIFTAXYS trademark a serial number of 79423293. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 9, 2025. This trademark is owned by MAAT PHARMA. The SIFTAXYS trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Medical and surgical apparatus and instruments for use in gastrointestinal surgery; drug delivery devices in the nature of medical apparatus and instruments for administration of pharmaceutical and biopharmaceutical products and preparations, namely, a kit comprising a suspension bag and administration tube set, sold empty; Drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, namely, syringes, infusion sets, implantable devices sold empty; drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, in the nature of a kit comprising a prefilled suspension bag and administration tube set sold without medication

Pharmaceutical and biopharmaceutical products and preparations for the medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction; pharmaceutical and biopharmaceutical products and preparations used for the treatment of cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; pharmaceuticals used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, n...
siftaxys

General Information


Serial Number79423293
Word MarkSIFTAXYS
Filing DateFriday, March 21, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 9, 2025

Trademark Statements


Goods and ServicesMedical and surgical apparatus and instruments for use in gastrointestinal surgery; drug delivery devices in the nature of medical apparatus and instruments for administration of pharmaceutical and biopharmaceutical products and preparations, namely, a kit comprising a suspension bag and administration tube set, sold empty; Drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, namely, syringes, infusion sets, implantable devices sold empty; drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, in the nature of a kit comprising a prefilled suspension bag and administration tube set sold without medication
Goods and ServicesPharmaceutical and biopharmaceutical products and preparations for the medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction; pharmaceutical and biopharmaceutical products and preparations used for the treatment of cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; pharmaceuticals used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 8, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, May 8, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMAAT PHARMA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NameMAAT PHARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Thursday, May 8, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, May 12, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 12, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, June 18, 2025ASSIGNED TO EXAMINER
Friday, June 20, 2025NON-FINAL ACTION WRITTEN
Saturday, June 21, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 7, 2025REFUSAL PROCESSED BY MPU
Friday, August 8, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, August 30, 2025REFUSAL PROCESSED BY IB
Wednesday, October 29, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 29, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 29, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 12, 2025EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 12, 2025EXAMINERS AMENDMENT E-MAILED
Wednesday, November 12, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 12, 2025EXAMINER'S AMENDMENT ENTERED
Wednesday, November 12, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 13, 2025NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, November 25, 2025NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 26, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 3, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 9, 2025PUBLISHED FOR OPPOSITION
Tuesday, December 9, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED